Creative Medical Technology Holdings (CELZ) Peer Comparison

$1.11

$0.05 (4.72%)

As on 04-Sep-2026 16:00EDT

Market cap

$7 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Market cap ($ Mln)	7	16,504	17,747	14,622	12,501
Revenue ($ Mln)	--	2,782	1,054	2,436	1,284
Net Profit ($ Mln)	-6.04	491.50	755.85	860.62	-325.10
Net Margin (%)	-201,355.37	17.67	71.69	35.33	-25.32
RoE (%)	-74.73	110.09	--	42.98	-57.72
Price to Earnings	--	34.72	20.93	18.56	--
Price-To-Book	0.84	38.18	10.51	7.95	23.94

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Operating Revenue	0.00	2,782.29	1,054.37	2,435.92	1,283.94
Cost of Revenue	0.08	1,982.07	103.47	85.67	109.42
Gross Profit	0.00	760.62	588.53	2,236.43	902.26
Operating Expenses	6.19	216.81	841.45	1,378.74	1,497.13
Operating Profit (EBIT)	-6.24	583.40	109.45	971.51	-322.62
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-6.04	598.92	101.11	1,035.47	-325.10
Provision for Tax	0.00	107.42	-654.74	174.84	0.00
Profit after Tax (Net Income)	-6.04	491.50	755.85	860.62	-325.10
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Shareholder's Funds	8.65	433.86	1,435.90	1,843.76	523.72
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.00	187.89	384.48	288.55	346.72
Current Liabilities	0.70	1,435.43	464.70	361.93	374.20
Total Liabilities	7.81	1,975.47	1,302.02	2,844.42	1,259.59

Assets ($ Mln)

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Non-Current Assets	0.36	1,006.90	895.24	1,243.41	45.47
Current Assets	9.02	1,050.29	1,389.84	1,250.82	1,199.18
Total Assets	7.81	1,975.47	1,302.02	2,844.42	1,259.59
Total Debt*	0.00	120.10	449.89	165.93	347.75
Net Current Assets	0.00	-385.14	925.52	888.90	824.98

Cashflow ($ Mln)

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Cash From Operating Activities	-5.86	713.22	51.77	884.27	-189.55
Cash Flow from Investing Activities	-0.05	-31.14	-8.15	350.44	32.32
Cash from Financing Activities	7.17	-860.39	34.89	-969.59	255.98
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
ROCE (%)	-86.36	53.56	-30.01	32.82	-31.49
ROE (%)	-74.73	110.09	163.18	42.98	-57.72
ROA (%)	-46.86	15.64	31.68	29.32	-22.97
EBIT Margin (%)	-206,767.73	21.13	5.73	31.04	-18.97
Net Margin (%)	-201,355.37	17.67	71.69	35.33	-25.32
Cash Profit Margin (%)	-2.22	0.00	0.00	0.00	0.00

Growth Ratios

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Revenue Growth (%)	-50.00	24.67	114.85	9.23	149.04
EBIT Growth (%)	-5.11	18.70	136.39	-3.99	9.16
Net Profit Growth (%)	-4.77	17.50	378.76	42.89	-15.32
EPS Growth (%)	35.14	26.84	353.27	50.42	-0.64
Book Value Growth (%)	-11.63	164.02	816.12	-0.70	-42.66

Valuation Ratios

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Price / Earnings	-0.78	36.06	-59.76	15.79	-45.32
Price / Book Value	0.84	38.18	10.51	7.95	23.94
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.00
EV/EBITDA	-0.02	27.00	230.43	13.21	-39.74
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debt to Equity	0.00	0.00	0.27	0.00	0.65
Short term debt to equity ratio	0.00	0.00	0.05	0.00	0.00
Current Ratio	12.91	0.73	2.99	3.46	3.20
Quick Ratio	12.73	0.73	2.32	3.38	2.94
Interest Coverage	--	--	1.62	--	-9.32

Operating Efficiency Ratios

	Creative Medical Technology Holdings (CELZ)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Madrigal Pharmaceuticals (MDGL)
Debtors to sales (%)	3,644.60	15.88	21.25	13.74	14.98
Asset Turnover	0.00	0.89	0.44	0.83	0.91
Receivable days	3,170.61	50.42	85.52	43.48	35.88
Inventory Days	182.63	--	1,056.70	96.17	354.23
Payable days	45,299.66	6.26	331.01	147.97	300.79
Cash Conversion Cycle	-41,946.42	--	811.21	-8.32	89.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly